Intravenous Chlorothiazide Versus Enteral Metolazone to Augment Loop Diuretic Therapy in the Intensive Care Unit

Annals of Pharmacotherapy

Volumn 51, Issue 4, 2017, Pages 286-292

  Michaud, Christopher J ^a   Mintus, Kendall C ^b  

^a SPECTRUM HEALTH   (United States)

^b MUNSON MEDICAL CENTER   (United States)

Author keywords

chlorothiazide; diuresis; intensive care unit; metolazone; sequential nephron blockade; thiazides

Indexed keywords

CHLOROTHIAZIDE; FUROSEMIDE; METOLAZONE; POTASSIUM; LOOP DIURETIC AGENT;

ADD ON THERAPY; ADULT; ALKALOSIS; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CRITICALLY ILL PATIENT; DIURESIS; DRUG COST; DRUG DOSE INCREASE; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODIALYSIS; HOSPITAL DISCHARGE; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; OUTCOME ASSESSMENT; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SURVIVAL; URINE VOLUME; COMBINATION DRUG THERAPY; CRITICAL ILLNESS; DRUG EFFECTS; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; CHLOROTHIAZIDE; CRITICAL ILLNESS; DIURESIS; DRUG THERAPY, COMBINATION; FEMALE; FUROSEMIDE; HUMANS; INTENSIVE CARE UNITS; MALE; METOLAZONE; RETROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 85014597928     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/1060028016683971     Document Type: Article

References (18)

1. Yancy CW, Jessup M, Bozkurt B. 2013 ACCF/AHA Guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240-e327.
2. Runyon BA, ; AASLD. Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013;57:1651-1653.
3. Khwaja A., KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-c184.
4. Kelm DJ, Perrin JT, Cartin-Ceba R. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock. 2015;43:68-73.
5. Cox ZL, Lenihan DJ., Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy. J Card Fail. 2014;20:611-622.
6. Neuberg GW, Miller AB, O’Connor CM, ; PRAISE Investigators. Prospective Randomized Amlodipine Survival Evaluation. Diuretic resistance predicts mortality in patients with advanced heart failure. Am Heart J. 2002;114:31-38.
7. Galiè N, Humbert M, Vachiery JL. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol (Engl Ed). 2016;69:177.
8. Asare K., Management of loop diuretic resistance in the intensive care unit. Am J Health Syst Pharm. 2009;66:1635-1640.
9. Wang DJ, Gottlieb SS., Diuretics: still the mainstay of treatment. Crit Care Med. 2008;36(1, suppl):S89-S94.
10. Jentzer JC, DeWald TA, Hernandez AF., Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010;56:1527-1534.
11. Lindenfeld J, Albert NM, Boehmer JP. HFSA 2010 comprehensive heart failure practice guideline. J Card Fail. 2010;16:e1-e194.
12. Kissling KT, Pickworth KK., Comparison of the effects of combination diuretic therapy with oral hydrochlorothiazide or intravenous chlorothiazide in patients receiving intravenous furosemide therapy for the treatment of heart failure. Pharmacotherapy. 2014;34:882-887.
13. Moranville MP, Choi S, Hogg J. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther. 2015;33:42-49.
14. Cardinale M, Altshuler J, Testani JM., Efficacy of intravenous chlorothiazide for refractory acute decompensated heart failure unresponsive to adjunct metolazone. Pharmacotherapy. 2016;36:843-851.
15. Shulenberger CE, Jiang A, Devabhakthuni S. Efficacy and safety of intravenous chlorothiazide versus oral metolazone in patients with acute decompensated heart failure and loop diuretic resistance. Pharmacotherapy. 2016;36:852-860.
16. Child DL, Cao Z, Seiberlich LE. The costs of fluid overload in the adult intensive care unit: is a small-volume infusion model a proactive solution? Clinicoecon Outcomes Res. 2014;7:1-8.
17. Besen BA, Gobatto AL, Melro LM. Fluid and electrolyte overload in critically ill patients: an overview. World J Crit Care Med. 2015;4:116-129.
18. Malbrain ML, Marik PE, Witters I. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46:361-380.